Status:
COMPLETED
Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Diabetes
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
Since the end of February 2020, Covid-19 infection has spread widely in France, particularly in the East region, with on March 25th, 2020, 5,479 infected patients and 407 deceased patients, including ...
Eligibility Criteria
Inclusion
- Adult diabetic patient (type 1,2, MODY, secondary, post transplantation) followed by diabetology consultation at the hospital or by a liberal diabetologist
- Subject affiliated to a social health insurance
- Subject able to understand the objectives of the research
- Subject who expressed his non opposition to the research
Exclusion
- Pregnant woman
- Patients with acute complications (foot ulcer, post stroke, post IDM)
- Cancer or life expectancy of less than 6 months
- Inability to provide informed information to the subject (subject in an emergency, difficulty of understanding for the subject, etc.)
- Subject under judicial protection
- Subject under guardianship or curatorship
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 29 2020
Estimated Enrollment :
610 Patients enrolled
Trial Details
Trial ID
NCT04370171
Start Date
May 4 2020
End Date
May 29 2020
Last Update
November 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg
Strasbourg, France